Hemp « AGORACOM Small-cap Investor Relations Blog

Posts Tagged ‘Hemp’

Empower Clinics $CBDT.ca Announces Closing of Acquisition of Sun Valley Clinics $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca $BUZZ.ca

Posted by AGORACOM-JC at 3:38 PM on Wednesday, May 1st, 2019

Completed the acquisition of Sun Valley Certification Clinics Holdings LLC
Operates a network of professional medical cannabis and pain management practices, with five clinics in Arizona, one clinic in Las Vegas, a tele-medicine platform serving California, and a fully developed franchise business model for the domestic cannabis industry
Will expand Empower’s multi-state operations, having a combined patient count of 165,000 patients, in Washington, Oregon, Illinois, Arizona, Nevada and California

VANCOUVER, May 1, 2019 -Â EMPOWER CLINICS INC. (CSE: CBDT) (Frankfurt 8EC)Â (“Empower” or the “Company“) is pleased to announce that, pursuant to the terms of a membership interest purchase agreement dated April 30, 2019, it has completed the acquisition of Sun Valley Certification Clinics Holdings LLC (“Sun Valley“) from Andrea Klein and Dustin Klein (together, the “Vendors“) and a minority shareholder, through its wholly-owned subsidiary, Empower Healthcare Assets Inc. (“Empower Health“), for cash and share consideration having an aggregate value of US$3,835,000Â (CAD$5,160,376), effective as of April 30, 2019 (the “Transaction“). Sun Valley operates a network of professional medical cannabis and pain management practices, with five clinics in Arizona, one clinic in Las Vegas, a tele-medicine platform serving California, and a fully developed franchise business model for the domestic cannabis industry.

In connection with the Transaction, Empower also acquired the 30% minority membership interests held by Green Global Properties Inc. (“Green Global“), a subsidiary of Aura Health Inc. (CSE: BUZZ), in three partially-owned subsidiaries of Sun Valley, operating clinics in Mesa and Phoenix, Arizona, and Las Vegas, Nevada, such that Empower now indirectly owns all of the membership interests in each of such subsidiaries (the “GG Acquisition“).

Over the past five years, Dustin and Andrea have built one of the most reputable and organized clinic networks in Arizona, developing a patient list of more than 45,000 unique patients, and have performed over 61,000 certifications to date. Sun Valley supports its patients with a dynamic dedicated team consisting of 52 staff, including 30 physicians.

“The acquisition of the Sun Valley clinic group has fundamentally changed the direction and growth prospects for Empower,” said Steven McAuley, Empower’s Chairman & CEO. “We have repositioned Empower as a vertically integrated global health and wellness company, helping consumers access products and specialized medical care for serious qualifying conditions. Having Dustin and Andrea Klein join me in leadership to rapidly expand Empower’s clinic and distribution network across the United States is a major step toward our ambitious objectives.”

“This acquisition is a testament to the hard work and dedication our team has provided to our community for the past five years and I look forward to being a valuable resource to the Company and on the board of directors,” said Dustin Klein, Sun Valley Co-founder.

Andrea Klein, Sun Valley Co-founder, stated, “I am delighted with our acquisition by Empower Clinics! It is the evolution of our dream, to positively affect the lives of patients across the country, and to become an adaptive and strategic organization that can harness the phenomenal and exciting growth of the cannabis industry. Steve’s vision for Empower is inspiring, and I am eager to bring our team together with his vision and grow into a dominating national brand that leads the way in patient care, employee satisfaction, and potential shareholder profitability!”

The Transaction is expected to create one of the largest clinic groups in the medical cannabis sector in the United States, which, together with Empower’s existing medical cannabis clinics, will expand Empower’s multi-state operations, having a combined patient count of 165,000 patients, in Washington, Oregon, Illinois, Arizona, Nevada and California, and the potential to rapidly expand the clinic network via the Sun Valley franchise program.

TRANSACTION HIGHLIGHTS

Improved Capital Markets Profile Empower is diversifying its business model to become a vertically integrated operator in the global cannabis sector with a focus on patient care, CBD product distribution, research & development and CBD product extraction. The Company believes this will appeal to a broader base of shareholders and investors and provide greater access to capital and improved trading liquidity.
Increased Patient Access With a rapidly expanding company-owned clinic network and significant expansion opportunity through the Sun Valley franchise model, Empower anticipates it will grow its total patient list substantially in the years ahead. This is expected to provide greater opportunity for treatment analysis using artificial intelligence (AI), validating the Company as a leader in understanding the efficacy of cannabis-related therapies.
Focus on CBD Product Sales Empower’s patient base and customers are expected to benefit from access to high margin derivative products, including CBD lotion, tinctures, spectrum oils, capsules, lozenges, patches, e-drinks, topical lotions, gel caps, hemp extract drops and pet elixir hemp extract drops. Patients and customers will be able to access Empower’s customer service, home delivery and e-commerce platform.
Market Leading Technology Empower utilizes a market-leading patient electronic management and POS system that is HIPAA compliant and provides deep insight to patient care. The Company supports remote patients using its tele-medicine portal, enabling patients who do not live near one of its clinic locations, or are disabled or unable to come to a location, to still benefit from a doctor consultation.
The Sun Valley Clinic Locations

4218 W Dunlap Ave, Phoenix, AZ
12801 W Bell Rd #145, Surprise, AZ
4015 E Bell Rd #130, Phoenix, AZ
2011 E University Dr, Mesa, AZ
7074 E Speedway Blvd, Tucson, AZ
2550 S Rainbow Blvd, Las Vegas, NV

In connection with the closing of the Transaction (the “Closing“), Empower: (i) paid the Vendors an aggregate cash payment of US$775,000 (CAD$1,042,840), of which US$150,000 (CAD$201,840) is being heldback by Empower, half of which is to be released six months from the date of Closing and the other half of which is to be release twelve months from the date of Closing and (ii) issued the Vendors an aggregate of 22,058,823 common shares in the capital of the Company (each a “Share“) at a deemed price of US$0.136 (CAD$0.183) per Share, representing the average daily closing price of the Shares on the Canadian Securities Exchange for the 10-day trading period ended April 26, 2019. 14,705,882 of the Shares will be held in escrow by Odyssey Trust Company pursuant to an escrow agreement dated April 30, 2019, and will vest in quarterly installments over 36 months from the date of the Closing. The Company also paid US$12,318 (CAD$16,575) and issued 350,602 Shares to a minority shareholder of one of the Sun Valley subsidiaries in order to acquire her minority interest therein.

Each of the Vendors have also entered into employment agreements with an affiliate of the Company pursuant to which Dustin Klein will serve as the Vice President of Business Development, and Andrea Klein will serve as the Vice President of Operations. In these roles, they will continue to provide their extensive industry knowledge and expertise to Sun Valley and the Company. In addition, Dustin Klein has been appointed as a director of the Company, effective as of the Closing.

In consideration for the GG Acquisition, Empower Health issued Green Global a promissory note in the principal amount of US$125,000, which bears interest at the rate of 4.0% per annum and has a maturity date of July 31, 2019.

None of the Shares to be issued in connection with the Transaction will be registered under the United States Securities Act of 1933, as amended (the “1933 Act“), or applicable state securities laws, and may not be offered or sold to, or for the account or benefit of, persons in the United States or “U.S. Persons” (as such term is defined in Regulation S under the 1933 Act), absent registration or an applicable exemption from such registration requirements.

ABOUT EMPOWER

Empower is a leading multi-state operator of a network of physician-staffed clinics focused on helping patients improve and protect their health through innovative physician recommended treatment options. It is expected that Empower’s proprietary product line “Sollievo” will offer patients a variety of delivery methods of doctor recommended cannabidiol (CBD) based products in its clinics, online and at major retailers. With over 165,000 patients, an expanding clinic footprint, a focus on new technologies, including tele-medicine, and an expanded product development strategy, Empower is undertaking new growth initiatives to be positioned as a vertically integrated, diverse, market-leading service provider for complex patient requirements in 2019 and beyond.

ON BEHALF OF THE BOARD OF DIRECTORS:

Steven McAuley
Chief Executive Officer

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include, but are not limited to, statements regarding the direction and growth prospects of the Company, the expansion of the company’s clinic and distribution network, the expected effect of the Vendors in their new roles with the Company, the effect on the lives of patients, the growth into a national brand, the effect of the Transaction, the diversification of the Company’s business model, the potential appeal to shareholders, the growth of the Company’s patient list and the effect thereof, the expected benefits for the company’s patient base and customers, the release of the cash consideration, the release of Shares being held in escrow in connection with the Transaction and statements regarding the Company’s proprietary product line “Sollievo”. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including that the Company may not be able to expand, that the Transaction may not have the expected results, and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.

SOURCE Empower Clinics Inc.

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/May2019/01/c3033.html

Investors: Steve Low, Boom Capital Markets, 647-620-5101; For French inquiries: Remy Scalabrini, Maricom Inc., E: [email protected], T: (888) 585-6274; Investors: Steven McAuley, CEO, [email protected], 604-789-2146Copyright CNW Group 2019

Tags: CBD, Hemp, Marijuana, stocks, tsx, tsx-v, weed
Posted in All Recent Posts, Empower Clinics Inc., Featured | Comments Off on Empower Clinics $CBDT.ca Announces Closing of Acquisition of Sun Valley Clinics $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca $BUZZ.ca

Bougainville and Project 470 Acres Enter the Canadian Hemp CBD Extraction Markets $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM at 12:37 PM on Thursday, April 25th, 2019

Positioning itself to capitalize on the growing Cannabidoil (â€œCBDâ€) market in Canada’s hemp industry
Entered into a binding letter of intent to create a joint venture with Project 470 Acres Ltd. to construct a 5,500 sq. ft. Hemp/CBD processing facility
Bougainville will contribute funding in the amount of $1 million CAD which will be used to acquire extraction equipment, build out infrastructure and fund working capital.

VANCOUVER, British Columbia, April 25, 2019 (GLOBE NEWSWIRE) — BOUGAINVILLE VENTURES INC. (“Bougainville” or the “Company”) (CSE:BOG; FRA: 8BV) is pleased to report the Company has positioned itself to capitalize on the growing Cannabidoil (â€œCBDâ€) market in Canada’s hemp industry by announcing that it has entered into a binding letter of intent (“LOI”) to create a joint venture with Project 470 Acres Ltd. (“Project 470”) to construct a 5,500 sq. ft. Hemp/CBD processing facility expandable to 10,000 sq. ft. with an option on additional lands for additional expansions as required. This purpose built facility is to be completed and scheduled for occupancy by the end of October 2019 for large scale CBD extraction.

Bougainville has also secured the first right of refusal for an adjacent 320 Acres and any additional locations and/or partner farmers garnered by Project 470 management to grow hemp, terms of which are to be determined in the Definitive Joint Venture Agreement. Each of the parties will receive a one-half share of the joint venture in exchange for their contributions:

Bougainville will contribute funding in the amount of $1 million CAD which will be used to acquire extraction equipment, build out infrastructure and fund working capital.
Project 470 has decades of experience working with co-op farmers in the Province of Saskatchewan, and will contribute operational expertise, will source additional properties, partner farmers, extraction equipment, staffing, manage operations; and, dedicate two quarter sections of land (320 acres) dedicated to hemp production. Subject to Board approval and completion of satisfactory due diligence, Bougainville intends to enter into a definitive agreement by May 31, 2019.

The completion of the Definitive Agreement is limited to the following;

the negotiation and execution of a definitive agreement, completion of satisfactory due diligence by Bougainville and Project 470; and
receipt of all required regulatory, corporate, Health Canada, permits, Canadian Securities Exchange requirements and any other conditions necessary to complete the transaction.

The Aberdeen Hemp Processing Facility

Aberdeen is located just north of Saskatoon, Saskatchewan, in the heart of the Canadaâ€™s second largest hemp producing province and has centralized access to both the Alberta and Manitoba hemp farm markets which will provide for reduced shipping costs enabling a cost effective process resulting in lower production costs. Expansion plans will include eventual cannabis extraction facilities upon receipt of Health Canada licensing.

Project 470â€™s management has commenced the process of obtaining relevant permits for its Aberdeen facility relating to the installation of drying equipment capable of drying over 1000 acres of flowers and leaves from surrounding farmers.The 5,500 square foot state-of-the-art facility will be unveiled during a ribbon cutting ceremony and grand opening event slated for October 15, 2019. The Aberdeen based hemp processorâ€™s goal is to become a leader in the production of CBD and related consumer products.

The Hemp Industry

The flowers and leaves of the hemp plant are rich in cannabinoids, notably containing non-psychoactive compounds of Cannabidiol. CBD, which has gained increasing popularity in recent years, has been found to be effective component in a complete personal wellness regimen. This has produced an increased demand from consumers for consumable products containing CBD. The Hemp Business Journal estimates that the CBD consumable markets will grow to a $2.1 billion market in consumer sales by 2020.

Andy Jagpal, President Comments;

â€œAs the hemp industry continues to grow, Bougainville is committed to setting the standard in high-quality, traceable CBD extract to capitalize on this rapidly growing, high margin market. This Joint Venture represents a great opportunity to continue expanding our footprint beyond the United States and to capitalize on Canadaâ€™s federal legal framework that is scheduled be in place to produce and sell Cannabidiol edible products by the fall of 2019.â€

About Bougainville Ventures, Inc.
Bougainville provides cannabis infrastructure and seed-to-sale services to I-502 tenant-growers leasing greenhouse facilities space and providing fully built-out, turnkey solutions and ancillary services including processing, cannabis expertise and marketing and sales resources. Greenhouse canopies provide a 50% saving in cultivation cost. Bougainville has 10,000 sq.ft., in near production in Oroville, WA, sufficient land for two more pods of the same size.

For more information please visit: http://bougainvilleinc.com/

On behalf of the Board of Directors
BOUGAINVILLE VENTURES INC.
_____________________
Andy Jagpal, CEO and Director

Tags: CSE, Hemp, Marijuana, stocks, tsx, tsx-v
Posted in Bougainville Ventures | Comments Off on Bougainville and Project 470 Acres Enter the Canadian Hemp CBD Extraction Markets $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

INTERVIEW: Bougainville $BOG.ca Accelerates Vertical Integration With 5 Marijuana Locations In Alberta + Hemp CBD In Oregon $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 6:09 PM on Tuesday, April 23rd, 2019

Bougainville (BOG:CSE) has laid a strong foundation for growth – literally – by establishing itself as the landlord to smaller USA marijuana growers that needed a turnkey solution. With it’s first tenant moving into 10,000 square feet this June in Washington State and adding another 20,000 thereafter, the Company is confidently branching out to become a vertically integrated producer and retailer in Canada.

Most companies would be happy with two lines of business but BOG is adding a 3rd line via Hemp CBD production in Oregon.

Watch this video to learn more about Bougainville Ventures (BOG:CSE).

Tags: CBD, CSE, Hemp, Marijuana, stocks, tsx, tsx-v, weed
Posted in AGORACOM Via Satellite, All Recent Posts, Bougainville Ventures | Comments Off on INTERVIEW: Bougainville $BOG.ca Accelerates Vertical Integration With 5 Marijuana Locations In Alberta + Hemp CBD In Oregon $CROP.ca $VP.ca NF.ca $MCOA

North Bud Farms Inc. $NBUD.ca â€“ #Pot stocks are soaring and the #cannabis industry is poised for ‘tons of growth’ $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 12:00 PM on Tuesday, April 23rd, 2019

SPONSOR: North Bud Farms Inc. (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Learn More.

Pot stocks are soaring and the cannabis industry is poised for ‘tons of growth’

Publicly traded cannabis companies have reported strong sales since Canada legalized pot last October and several US states voted to approve recreational and medical marijuana use
Cannabis has also gone mainstream thanks to big investments and partnerships between marijuana sellers and blue chip consumer companies.

New York (CNN Business) For decades, though nobody was really sure why, April 20 has been the unofficial holiday for marijuana users and a joke by and about them. Now, though, it’s also a reminder of how quickly marijuana is moving from illegal and a joke to a multi-billion dollar legal business â€” and a good time for us to take another look at how well cannabis stocks have been doing. Publicly traded cannabis companies have reported strong sales since Canada legalized pot last October and several US states voted to approve recreational and medical marijuana use. Cannabis has also gone mainstream thanks to big investments and partnerships between marijuana sellers and blue chip consumer companies. Corona owner Constellation Brands (STZ) has a more than 35% stake in Canopy Growth (CGC), a Canadian cannabis company that intends to take a bigger step into the United States with plans to buy American cannabis firm Acreage Holdings. Constellation also disclosed Thursday it may eventually boost its stake in Canopy to 50%. Â Pot stocks may be a bubble that needs to burst Marlboro-owner Altria (MO) invested $1.8 billion in cannabis producer Cronos Group (CRON). And Tilray (TLRY) is working on cannabis-infused drinks with Budweiser owner AB InBev (BUD). But many of these stocks have soared this year already â€” Cronos is up nearly 60% so far while Canopy has gained 70% â€” leading to questions about whether this is just a speculative mania like tulips and dot-com companies.

Bubble or bargain?

“This business is still in its infancy. It’s like investing in alcohol post-Prohibition. There will be tons of growth,” said Dan Ahrens, chief operating officer with investment firm AdvisorShares. “But there are going to be home runs and there will be lots of strikeouts.” Ahrens thinks that investors need to be patient and selective. But he believes they will be rewarded â€” that is, if they wind up picking the winners. “These are new, up and coming companies. There is going to be volatility so you have to be selective,” Ahrens said, adding that he favors companies that haven’t already shot up because they’ve done big deals like Canopy and Cronos have. Ex-NFL player Tiki Barber now invests in pot AdvisorShares just launched the Pure Cannabis ETF (YOLO), an actively managed fund that invests in cannabis stocks. Some of its top holdings are Canadian cannabis companies CannTrust (CTST), Aphria (APHA) and Hexo (HEXO). Canopy Growth co-CEO: Product opportunity is ‘substantial’05:27 Rob Almeida, global investment strategist with MFS Investment Management, said investors may be getting ahead of themselves. He’s worried that cannabis stocks are going to turn out to be an investing fad like 3D printing and blockchain companies. “Cannabis is not going to have parabolic growth,” Almeida told CNN Business. “There is a lot of hope and enthusiasm.”

Cannabis prices are falling

One cause for concern: Now that more states are legalizing marijuana use, prices are dropping as competition has increased. Research firm BDS Analytics, which calculates a consumer price index for the cannabis industry in the United States, recently reported that overall prices in February for products such as ingestibles, topical creams, vaporizers and vape pens and pre-rolled joints, fell 2.7% from February of 2018. Prices were down nearly 2% from the prior month. Many of the publicly traded cannabis companies have been reporting a drop in the retail price in Canada since legalization last October as well. Aphria, for example, reported sales this week that missed forecasts. Shares plunged nearly 15% on the news. But the stock is still up more than 40% so far in 2019.

More deals likely on the way

A lot of the excitement has to do with expectations of more mergers and partnerships. Aurora Cannabis (ACB), a Canadian company whose stock has soared 80% this year, recently announced that it was adding legendary investor and deal maker Nelson Peltz as an adviser. That’s led to speculation that Peltz may help Aurora team up with a consumer products or healthcare company. Tilray, for example, also has a strategic relationship with generic drug maker Sandoz, a subisidiary of Novartis (NVS). So other cannabis firms may look to team up with Big Pharma. Canopy’s plans to buy Acreage could lead to another wave of consolidation too. Matt Hawkins, managing principal at Cresco Capital Partners and an investor in Acreage, said in an email to CNN Business that “this is the moment the cannabis sector knew was coming — consolidation.” Hawkins added that the deal “will lead to a rush of cannabis companies merging in order to compete with Canopy/Acreage” and that “it’s now going to be very hard for early start-ups to enter the space and compete with the growing/emerging conglomerates.” In other words, there’s another sign that cannabis is going legit: It’s starting to function just like any other major consumer industry. Source: https://www.cnn.com/2019/04/19/investing/cannabis-stocks-420/index.html

Tags: CSE, Hemp, Marijuana, stocks, tsx, tsx-v, weed
Posted in All Recent Posts, North Bud Farms Inc | Comments Off on North Bud Farms Inc. $NBUD.ca â€“ #Pot stocks are soaring and the #cannabis industry is poised for ‘tons of growth’ $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

North Bud Farms Inc. $NBUD.ca â€“ How to Value a #Pot #Cannabis Stock $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 11:32 AM on Thursday, April 18th, 2019

How to Value a Pot Stock

By Tara Lachapelle and Sarah Halzack

While cannabis investors are distracted by seeds and crop yields, corporations with M&A in mind see a more lucrative future in brand-building and retail.

Cannabis growers have hardly any revenue and their product is still illegal in their most desirable market, the U.S. Thatâ€™s not stopping investors and corporate giants from spending billions of dollars to take stakes in these companies. They obviously see growth potential. And yet the question remains, how do you even value a pot business?

Altria Group Inc., the U.S. tobacco leader and maker of Marlboro cigarettes, announced in December that it was buying 45 percent of Cronos Group Inc., one of Canadaâ€™s growing number of cannabis producers and among the industryâ€™s high-flying stocks. The $1.8 billion transaction left us wondering: How did Altria determine that price? After all, in the period before the deal, Cronos generated sales of less than $4 million â€“ no, thatâ€™s not a typo â€“ and certainly no profits. Recreational pot had only just become legal in Canada two months earlier. Altria, a $105 billion market-cap company that rarely does splashy deals, placed immense value on a barely existent business in a nascent market.

The dynamics were the same when Constellation Brands Inc., a beer and liquor conglomerate, spent $3.8 billion to increase its stake in Canopy Growth Corp. earlier in 2018. Canopyâ€™s CEO has said he wants it to become the Google of pot â€“ but heâ€™ll need to add a few more digits to its sales figures.

Seeing Green

The projected growth of the worldwide cannabis market has some investors pouring money into newcomer companies with tiny revenue and no profits

Source: Arcview Market Research, BDS Analytics

Itâ€™s a tricky thing to gauge the worth of assets that will potentially be highly valuable down the road â€“ but are difficult to quantify just yet. Looking at other industries where this has been the case is helpful. Even if their businesses arenâ€™t perfect comparisons, the method of valuing them can be instructive.

Take the natural-resources space, where the focus is often on non-financial metrics. They include production capacity and tangible assets, such as proved oil reserves â€“ which is to say, how much fuel a producer can likely pump from their land. It can be argued that this is similar to how individual investors already have been gauging cannabis companies, dazzled by how many kilograms can be produced and how many acres of greenhouse they have.

But the downside to this approach for cannabis is that it puts too much emphasis on supply-chain processes that may become commoditized, and a rudimentary focus on capacity doesnâ€™t capture how the early movers in this market can differentiate themselves. The industryâ€™s novelty also distracts from what can be a challenging business from an operational standpoint. For example, Aphria Inc.â€™s share price increased more than elevenfold over the last five years, but in its latest quarter the business was hamstrung by supply shortages and packaging issues.

A better comparison for cannabis may be the biotechnology space. Deals for drug developers involve big, risky bets on future potential blockbusters. These products may not generate revenue yet, but they aim to address very specific markets and are expected to have an economic moat that wards off competition. For pharmaceuticals, that moat comes from patent exclusivity that prevents copycat versions of a therapy. In some ways, this is what the more advanced cannabis companies are looking to accomplish. They wonâ€™t have patents in the same way, but they do aim to create intellectual property and specialized brands that appeal to certain types of customers. And they want to be first to form those customer relationships.

Remember, this market will be far more expansive than simply selling a box of joints. Thereâ€™s an opportunity to create all sorts of consumer products, and the marketing can vary widely â€“ from wellness drinks and beauty items infused with cannabidiol, or CBD (the part of cannabis that doesnâ€™t deliver a high), to â€œsinâ€ products like marijuana-infused edibles, or something more akin to having a glass of wine.

Taking Off

As the recreational cannabis market surpasses the medical one, it will become increasingly important for companies to create compelling brands

Source: Arcview Market Research, BDS Analytics

Look at it this way: Altria doesnâ€™t own tobacco farms. It owns high-margin brands that source from tobacco growers. So when itâ€™s studying the future of marijuana, itâ€™s not looking solely at production. Itâ€™s looking for unique brands that can be scaled up by a team with the necessary know-how. In the case of Cronos, CEO Mike Gorenstein said on the last earnings call that the company is trying to differentiate itself with pre-rolled joints, adding that innovation around branding and efficiency will be â€œa bigger differentiator than just cultivation.â€

Knowing the important role that brand-building will play in the next phase of the cannabis industryâ€™s growth story, itâ€™s useful to study these companiesâ€™ senior management teams and look for branding and retail pedigree. Itâ€™s a good sign that Cronosâ€™s head of marketing has had stints at PepsiCo Inc. and Mondelez International Inc., and that Tilray Inc. has a one-time Starbucks Corp. executive running its retail strategy.

Green Growth Brands Inc., based in Ohio and Ontario, has a deep bench of such leaders: Its CEO is Peter Horvath, a former executive at American Eagle Outfitters Inc., Victoriaâ€™s Secret and DSW. His key deputies come from the likes of Abercrombie & Fitch Inc. and Bath & Body Works. They are rightly emphasizing that retail expertise is a point of distinction and an advantage as they develop targeted brands such as Green Lily, aimed at women, and Camp, aimed at active, outdoorsy types. This brand-centricity seems to be paying off: Even though Green Growth doesnâ€™t have as large a market capitalization as the Canada-based players, it recently scored a partnership with Simon Property Group Inc. to open more than 100 CBD stores in the mall giantâ€™s shopping centers, and its CBD products will be sold in 96 DSW locations.

That U.S. footprint might do it good down the road, as wider marijuana legalization seems likely. While much of the focus these days is around the promise of the Canadian market, itâ€™s important not to let that obscure what should be the cannabis worldâ€™s real end game.

Sizing Up The U.S. Prize

California alone has a larger population than Canada, illustrating why the U.S. remains such a tantalizing opportunity for the cannabis industry

Source: Statistics Canada, U.S. Census Bureau

And, in general, the Canadian companies that have received such bountiful investor buzz are at something of a disadvantage on the branding front, notes Bethany Gomez, a cannabis industry analyst at Brightfield Group. Because of strict rules in Canada regarding logo size and other packaging details for currently available cannabis products, they are simply limited in how distinctive they can make their presentation.

Wherever itâ€™s sold, if the cannabis business is to grow as big as the industryâ€™s bulls hope, it is going to have to successfully court non-users and infrequent users. Thatâ€™s where newer innovations, such as edibles and beauty items, may be more important than smokeable products.

Not Quite Cannabis Crazy

In U.S. markets that have legalized recreational marijuana, many people are still not consuming cannabis, underscoring the opportunity to grow addressable market

Source: BDS Analytics Consumer Insights

The companies that become the breakout stars in the legal cannabis era will be the ones that have a vision for how to create demand for such goods, whether through curiosity-inducing product, a great in-store experience or alluring marketing. These capabilities â€“ not merely spreading more seeds in soil â€“ should be a critical part of valuing the pot pioneers.

Source: https://www.bloomberg.com/opinion/articles/2019-04-18/altria-shows-there-s-a-better-way-to-value-cannabis-stocks

Tags: Cannabis, CSE, Hemp, Marijuana, stocks, tsx, tsx-v, weed
Posted in All Recent Posts, North Bud Farms Inc | Comments Off on North Bud Farms Inc. $NBUD.ca â€“ How to Value a #Pot #Cannabis Stock $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Empower $EPW.ca announces partnership with Cannvas Medtech to advance patient education $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 8:10 AM on Thursday, April 18th, 2019

Announced the signing of pilot agreement with Cannvas MedTech Inc.
The partnership installs Cannvas as the exclusive provider of cannabis education to Empower Clinics and its 120,000 patients in the U.S.

Empower Clinics Inc. is launching a pilot program with Cannvas MedTech to place educational kiosks in each of its clinics to advance the education of patients, collection of data and analysis of physician recommended alternative CBD based therapies.

VANCOUVER, April 18, 2019 – EMPOWER CLINICS INC. (CSE: CBDT) (Frankfurt 8EC) (“Empower” or the “Company“), a growth oriented, diversified health and wellness company, is pleased to announce the signing of a pilot agreement with Cannvas MedTech Inc. (“Cannvas”) (CSE: MTEC) (FRA: 3CM)Â (OTCPK: CANVF), a leading digital cannabis education and analytics company, to launch a comprehensive education, data collection and analysis program starting with the installation of a network of standalone on-site Cannvas Kiosks in the Empower network of medical clinics.

“This is an opportunity to bring unbiased cannabis education to a large population of patients looking for therapies to alleviate a number of ailments while also learning more about what behaviours may drive the decision to look at cannabis as an alternative or complementary treatment,” said Shawn Moniz, Chief Executive Officer, Cannvas MedTech. “We are thrilled to partner with Empower Clinics to couple cannabis education with data analysis and better serve their patients while growing the Cannvas brand across the United States.”

The partnership installs Cannvas as the exclusive provider of cannabis education to Empower Clinics and its 120,000 patients in the U.S. Cannvas plans to place its Cannvas Kiosks throughout Empower’s network of clinics to provide accessible and unbiased cannabis education to its patients, integrating geo-targeting capabilities to ensure relevant contextual information across the country. Cannvas will also be a key data and analytics partner for Empower, providing meaningful insights on customer behaviours and industry trends and integrating mutually beneficial existing data partnerships.

“In recent weeks, the Company has been re-positioning its overall strategy to become a vertically integrated health and wellness company that connects to its 120,000 patients using a data driven focus to improve patients’ lives with products, technology and health systems”, stated Steven McAuley, Empower CEO, “the addition of the Cannvas educational kiosks, a user friendly and highly interactive education platform, is a tremendous step forward to making our brand the thought leader and go to source for content for both patients and the medical community nationwide.”

Every month Empower hosts informational sessions about alternative treatment options and the potential health benefits with doctors and staff available to answer questions. Cannvas expects to play an active role in the review and implementation of new educational curriculum based on original content from Cannvas.Me.

The Company also plans to begin further pilot initiatives with Cannvas to provide content and educational links to Cannvas.me and Cannvas.health directly from the new Empower website www.empowerclinics.com and through the Empower tele-medicine portal.

ABOUT EMPOWER

Empower is a leading owner/operator of a network of physician-staffed clinics focused on helping patients improve and protect their health through innovative physician recommended treatment options. It is expected that Empower’s proprietary product line “Sollievo” will offer patients a variety of delivery methods of doctor recommended cannabidiol (CBD) based products in its clinics, online and at major retailers. With over 120,000 patients, an expanding clinic footprint, a focus on new technologies, including tele-medicine, and an expanded product development strategy, Empower is undertaking new growth initiatives to be positioned as a vertically integrated, diverse, market-leading service provider for complex patient requirements in 2019 and beyond.

ABOUT CANVASS MEDTECH

Cannvas MedTech is a leading digital cannabis education and analytics company delivering accessible and evidence-based education while harnessing the power of data to paint a clearer picture of cannabis consumption across Canada.

For French inquiries: Remy Scalabrini, Maricom Inc., E: [email protected], T: (888) 585-6274

ON BEHALF OF THE BOARD OF DIRECTORS:

Steven McAuley
Chief Executive Officer

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include statements regarding the Company’s proposed name change; new website; and the expected benefits of same for the Company and its stakeholders. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including: that the proposed acquisitions and partnerships, including that: the name change may not be approved by the Company’s shareholders or may not be completed; that the website may not operate as expected; that the Company may not be able to obtain adequate financing to pursue its business plan; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed acquisitions and partnerships; and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.

SOURCE Cannvas MedTech Inc.

View original content: http://www.newswire.ca/en/releases/archive/April2019/18/c0328.html

Tags: CSE, Hemp, Marijuana, stocks, tsx, tsx-v, weed
Posted in Empower Clinics Inc. | Comments Off on Empower $EPW.ca announces partnership with Cannvas Medtech to advance patient education $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

CLIENT FEATURE: NORTHBUD $NBUD.ca Signs $20 MILLION Binding LOI For Acquisition of Multi-State Licensed Operator Eureka Vapor WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 4:19 PM on Wednesday, April 17th, 2019

WHY NORTHBUD FARMS?

Canadian regulatory door for CIP (Cannabinoid Infused Products) is opening this year
as shown in other legal jurisdictions (Colorado, Washington, Nevada, California)
Infused products sector has become the highest margin segment of the industry
Positioned to be a raw input producer for this space
Currently working with multiple food, beverage and science companies to provide safe standardized cannabinoid infused raw inputs for large scale GMP manufacturing of products
Signed Binding Letter of Intent to Enter U.S. Market with Strategic Acquisition of Multi-State Licensed Operator Eureka Vapor Read Release

CHECK OUT OUR RECENT INTERVIEW

FULL DISCLOSURE: NORTHBUD is an advertising client of AGORA Internet Relations Corp.

Tags: CSE, Hemp, Marijuana, stocks, tsx, tsx-v, weed
Posted in All Recent Posts, North Bud Farms Inc | Comments Off on CLIENT FEATURE: NORTHBUD $NBUD.ca Signs $20 MILLION Binding LOI For Acquisition of Multi-State Licensed Operator Eureka Vapor WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Marijuana Company of America $MCOA Completes Agreement for Cannabis Extraction, Distribution and Delivery Licenses $AERO $CBDS $CGRW $APH.ca $GBLX $ACG $ACB $WEED.ca $HIP.ca

Posted by AGORACOM-JC at 9:31 AM on Wednesday, April 17th, 2019

Company has officially acquired a 20% ownership interest in Natural Plant Extract of California (NPE).
Under the terms of the agreement, Marijuana Company of America has committed to contribute $2,000,000 in total cash to the project, as well as common shares of the Company with a value of $1,000,000.

Escondido, California–(April 17, 2019) – MARIJUANA COMPANY OF AMERICA INC. (OTCQB: MCOA) (“MCOA” or the “Company“), an innovative hemp and cannabis corporation, is pleased to announce that the Company has officially acquired a 20% ownership interest in Natural Plant Extract of California (NPE).

Under the terms of the agreement, Marijuana Company of America has committed to contribute $2,000,000 in total cash to the project, as well as common shares of the Company with a value of $1,000,000. In exchange, the Company will own a 20% equity position in NPE. In addition, MCOA and NPE have also officially signed a Joint Venture Agreement (JV) to establish Viva Buds as a premier cannabis delivery company. Both NPE and MCOA will share in the profits on a fifty-fifty basis.

Viva Buds Inc. will serve as the marketing arm for NPE subsidiary Northern Lights Distribution’s (NLD) new retail cannabis delivery service in California, first starting with delivery services to Los Angeles County and then rolling out to other major cities throughout the state. NLD will contribute up to $300,000 in inventory of cannabis products to assist in the start-up of this venture, and MCOA will provide a vast array of marketing services and technology to promote and build its Viva Buds brand.

NPE owns both state and city licenses for volatile manufacturing, distribution and retail delivery of cannabis products. NPE will manage all operations pertaining to distribution, manufacturing and delivery of cannabis products, and MCOA will provide capital, consulting and marketing services. NPE is currently operating as a distributor and is completing the build-out of its manufacturing facility, which is expected to be completed and fully operational in August 2019.

Regarding the acquisition, Alan Tsai, CEO of NPE, stated, “We are excited to be one of the first California licensed cannabis companies to partner with a publicly traded company in the US. We believe that partnering with an established company such as Marijuana Company of America will help to build Viva Buds and establish our foothold early by securing manufacturing and distribution contracts with key players in the California cannabis market. We expect that this strategic partnership will be mutually beneficial to both companies.”

Don Steinberg, MCOA CEO, stated, “After a great deal of due diligence and strategic planning, we are happy to execute an agreement to purchase ownership in NPE. This is a major step in staying true to our name Marijuana Company of America and entering into the marijuana industry in California. We have aspirations of becoming a major distributor, delivery service and manufacture in California. NPE is ahead of most of the competition in the state in terms of permitting, build-out and licensing.”

About Marijuana Company of America, Inc.
MCOA is a corporation that participates in: (1) product research and development of legal hemp-based consumer products under the brand name “hempSMART™,” which targets general health and well-being; (2) an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD; (3) leasing of real property to separate business entities engaged in the growth and sale of cannabis in those states and jurisdictions where cannabis has been legalized and properly regulated for medicinal and recreational use; and, (4) the expansion of its business into ancillary areas of the legalized cannabis and hemp industry, as the legalized markets and opportunities in this segment mature and develop.

About Natural Plant Extracts of California
NPE is a fully licensed cannabis manufacturing, distribution and non-store front retail delivery. The Company has secured its licenses with the state of California and city of Lynwood, CA. For more information about the Company, please visit its website at https://nldistribution.com

The owners and founders of NPE are marijuana industry veterans with decades of experience in establishing retail, manufacturing and distribution of cannabis in California, including obtaining the first retail dispensary licenses in Los Angeles, CA.

Forward Looking Statements
This news release contains “forward-looking statements,” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan” or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future US and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-12G, our quarterly reports on Form 10-Q and other periodic reports filed from time to time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

Contact:

[email protected]
888-777-4362

For more information, please visit the Company’s websites at:

MarijuanaCompanyofAmerica.com
hempSMART.com
NetworkNewsWire/MCOA

Corporate Communications:
NetworkWire (NW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
[email protected]

Tags: CSE, Hemp, Marijuana, stocks, tsx, tsx-v, weed
Posted in Marijuana Company of America | Comments Off on Marijuana Company of America $MCOA Completes Agreement for Cannabis Extraction, Distribution and Delivery Licenses $AERO $CBDS $CGRW $APH.ca $GBLX $ACG $ACB $WEED.ca $HIP.ca

Bougainville $BOG.ca to Acquire an Interest in Five Alberta Retail Locations #Marijuana #Cannabis $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 9:11 AM on Monday, April 15th, 2019

Entered into a non-binding letter of intent dated April 12, 2019, to acquire a 25% ownership interest in five Mountain Mellow Alberta locations
Mountain Mellow management is in their final stage of AGLC approval, has secured two prime retail locations in the Province of Alberta and is in the process of securing a minimum of three more.

VANCOUVER, British Columbia, April 15, 2019 — BOUGAINVILLE VENTURES INC. (“Bougainville” or the “Company”) (CSE:BOG) is pleased to announce that it has entered into a non-binding letter of intent (the “LOI”) dated April 12, 2019, to acquire a 25% ownership interest in five (5) Mountain Mellow Alberta locations in exchange for cash and common shares of Bougainville Ventures, Inc.

Mountain Mellow management is in their final stage of AGLC approval, has secured two (2) prime retail locations in the Province of Alberta and is in the process of securing a minimum of three (3) more. Mountain Mellow locations may be leased and/or owned and will have continuous daily traffic of no less than 5,000 drive by vehicles per day.

Andy Jagpal, President of Bougainville says, “Bougainville has gained a tremendous opportunity with Mountain Mellow to become the Premier Cannabis retailer in Alberta. Mountain Mellow and Bougainville Ventures are committed to providing the perfect consumer retail experience and Mountain Mellow will add to the Bougainville strategy in its retail expansion.â€

Pursuant to the terms of the LOI, the Company will acquire 25% of the issued and outstanding common shares in the capital of Mountain Mellow in exchange for Two hundred and Fifty Thousand ($250,000.00) Canadian dollars plus Seven Hundred and Fifty thousand ($750,000.00) in common shares shareâ€™s at a deemed share value as set at close of market on the fifteenth (15) day after the opening of each AGLC approved and occupancy permitted location, for an aggregate consideration of $5,000,000. Bougainville has also secured the right of first refusal for any additional locations garnered by Mountain Mellow management, terms of which are to be determined in the Definitive Agreement.

The completion of the Definitive Agreement is limited to the following; (i) the negotiation and execution of a definitive agreement, (ii) completion of a satisfactory due diligence by Bougainville and Mountain Mellow; and (iii) receipt of all required regulatory, corporate, permits, Canadian Securities Exchange requirements and any other conditions necessary to complete the transaction.

About Bougainville Ventures, Inc.Â
Bougainville provides cannabis infrastructure and seed-to-sale services to I-502 tenant-growers leasing greenhouse facilities space and providing fully built-out, turnkey solutions and ancillary services including processing, cannabis expertise and marketing and sales resources. Greenhouse canopies provideÂ a 50% saving in cultivation cost. Bougainville has 10,000 sq.ft., in near production in Oroville, WA.Â

For more information please visit:Â http://bougainvilleinc.com/Â

On behalf of the Board of DirectorsÂ
BOUGAINVILLE VENTURES INC.Â

Andy Jagpal, CEO and DirectorÂ

For further information, please contact Andy Jagpal atÂ [email protected]Â or by phone at 1-888-395-6399

Tags: CSE, Hemp, Marijuana, stocks, tsx, tsx-v, weed
Posted in Bougainville Ventures | Comments Off on Bougainville $BOG.ca to Acquire an Interest in Five Alberta Retail Locations #Marijuana #Cannabis $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Marijuana Company of America $MCOA Reports 840% Year Over Year Revenue Growth for Year End 2018 $AERO $CBDS $CGRW $APH.ca $GBLX $ACG $ACB $WEED.ca $HIP.ca

Posted by AGORACOM-JC at 8:11 AM on Monday, April 15th, 2019

Company Cites Other Positive Financial Developments Which Include Decrease in SG&A Expenses and Significant Improvements on Balance Sheet

Total revenues of hempSMART™ products were $252,135 for the year ended Dec. 31, 2018, as compared to $26,830 from the prior year, representing a significant 840% increase year over year.
Gross profit for 2018 increased to $170,885, a 68% gross margin, compared to a gross margin of $12,536 for 2017, a 47% gross margin

Escondido, California–(April 15, 2019) – MARIJUANA COMPANY OF AMERICA INC. (OTCQB: MCOA) (“MCOA” or the “Company”), a vertically integrated hemp and cannabis corporation, is pleased to announce its financial results for the year ended Dec. 31, 2018, as reported in its annual report on Form 10-K.

2018 Financial Highlights

Total revenues of hempSMART™ products were $252,135 for the year ended Dec. 31, 2018, as compared to $26,830 from the prior year, representing a significant 840% increase year over year.
Net loss from operations decreased by 82% from $21,262,798 for the year ended Dec. 31, 2017, to $3,814,949 from the prior year.
Gross profit for 2018 increased to $170,885, a 68% gross margin, compared to a gross margin of $12,536 for 2017, a 47% gross margin.
SG&A expenses, including non-cash items and one-time transactional expenses, for 2018 decreased substantially by $17,292,265, or 81%, to $3,980,493, compared to $21,272,758 for the prior year.
For the year ended Dec. 31, 2018, the Company realized the following other one-time income items: Gain cancellation of debt of $1,500,000 and a gain of $560,000 from the change in value of its trading securities investment in Global Payout. The Company also settled a debt that resulted in a gain of $94,933.
Total assets increased by 70% from $1,129,958 in 2017 to $1,919,781 in 2018. This increase is due primarily to the increase in value of the Company’s investment in Global Payout’s stock, which is accounted for using the trading security method of accounting as well as an increase in cash and inventory.
Total liabilities decreased by 56% from $11,447,710 for 2017 to $5,053,887 for 2018. This decrease was largely due to the decrease in liabilities related to warrants and joint venture obligations.
Cash used by operating activities for 2018 was $2,385,349, compared to cash used for operating activities of $895,743 for 2017. Cash used by investing was $686,458, compared to $1,176,919 for 2017. Cash provided by financing activities for 2018 was $3,181,553, compared to $2,175,007 for 2017.

“I could not be prouder of the growth and accomplishments our company and team members achieved in 2018,” said Don Steinberg, founder, chairman and CEO of Marijuana Company of America. “Our industry experienced unprecedented legislative developments, including Canada going full adult use and the Farm Bill passing in the U.S. We are now better positioned than ever to be a leader in the cannabis industry. Not only did we expand our team, but we also launched our hempSMART sales in Europe. We expect to complete and announce our acquisition of a California marijuana manufacturing and distribution license shortly. Upon completion, this acquisition will allow us to capture additional market share, implementing a fully integrated cannabis model that includes cultivation of hemp, distribution and manufacturing of cannabis, and the retail delivery of our new Viva Buds brand.”

Jesus Quintero, CFO of Marijuana Company of America, said, “We are very pleased with the strong financial results of 2018. Our financial results were better than many other cannabis public companies in our sector, which are still in the development stage and not yet producing revenue. Marijuana Company of America, through our hempSMART brand, has experienced a dramatic increase in sales, most of which occurred in fourth quarter. This trend is continuing to grow in first and second quarter of 2019. We think our shareholders are going to be very satisfied with the execution of our highly aggressive growth and restructuring plans in 2019.”

Further details about the Company’s financial results are available in its annual report on Form 10K, which will be available in the investor relations section of the Company’s website at www.marijuanacompanyofamerica.com.

About Marijuana Company of America, Inc.

MCOA is a corporation that participates in: (1) product research and development of legal hemp-based consumer products under the brand name “hempSMART™” that target general health and well-being; (2) an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD; (3) leasing of real property to separate business entities engaged in the growth and sale of cannabis in those states and jurisdictions where cannabis has been legalized and properly regulated for medicinal and recreational use; and (4) the expansion of its business into ancillary areas of the legalized cannabis and hemp industry as the legalized markets and opportunities in this segment mature and develop.

About Our hempSMART Products Containing CBD

The United States Food and Drug Administration (FDA) has not recognized CBD as a safe and effective drug for any indication. Our products containing CBD derived from industrial hemp are not marketed or sold based upon claims that their use is safe and effective treatment for any medical condition as drugs or dietary supplements subject to the FDA’s jurisdiction.

Forward-Looking Statements

This news release contains “forward-looking statements” that are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities, and words such as “anticipate,” “seek,” “intend,” “believe,” “estimate,” “expect,” “project,” “plan,” or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-12G, our quarterly reports on Form 10-Q and other periodic reports filed from time to time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.